# EGF stimulation
# Time Experiment 1 Experiment 2 Experiment 3 Experiment 4
0 9.03 3.78 3.29 3.34
2 7.03 4.77 3.78 2.75
5 34.49 34.49 30.66 24.31
10 23.71 20.26 34.49 34.49
20 9.03 6.67 7.41 5.09
40 7.90 5.10 4.85 3.91 

# Cilostamide stimulation
# Time Experiment 1 Experiment 2 Experiment 3
0 5.04 4.47 3.74
2 6.72 3.63 2.22
5 61.72 77.92 52.82
10 45.93 87.52 54.62
20 16.96 18.48 11.11
40 6.04 5.96 4.39 

# EPAC agonist stimulation.
# Time Experiment 1 Experiment 2 Experiment 3
0 3.96 2.84 3.92
2 7.63 7.57 6.60
5 61.12 56.63 56.75
10 39.83 49.63 51.54
20 10.33 9.00 6.94
40 5.40 4.91 4.14 

# PKA agonist stimulation.
# Time Experiment 1 Experiment 2 Experiment 3
0 4.16 3.15 3.40
2 4.33 3.19 3.23
5 24.69 27.04 16.98
10 16.86 21.82 24.87
20 8.03 5.41 4.82
40 5.87 4.51 3.68

# Cilostamide and EPAC stimulation.
# Time Experiment 1 Experiment 2 Experiment 3
0 5.89 3.57 4.02
2 22.48 22.99 5.09
5 73.63 90.76 66.43
10 51.31 46.28 78.12
20 10.88 16.14 11.64
40 5.32 6.84 4.81

# Cilostamide and PKA agonist stimulation.
# Time Experiment 1 Experiment 2 Experiment 3
0 6.53 4.16 2.56
2 9.73 6.00 5.64
5 78.98 80.19 52.69
10 53.42 67.72 49.20
20 10.27 12.86 10.25
40 8.17 4.55 4.23

# EPAC and PKA agonist stimulation.
# Time Experiment 1 Experiment 2 Experiment 3
0 5.06 4.11 3.75
2 10.36 7.27 4.77
5 46.72 38.85 30.17
10 50.00 32.02 27.09
20 10.44 6.52 6.02
40 6.65 4.04 4.55

# EPAC and PKA agonists stimulation in the presence of cilostamide.
# Time Experiment 1 Experiment 2 Experiment 3
0 6.92 3.26 3.51
2 38.56 26.06 20.21
5 100.00 64.48 63.24 
10 73.15 58.24 46.89
20 9.12 10.23 9.41
40 7.00 6.16 4.20 
